Components:
Medically reviewed by Oliinyk Elizabeth Ivanovna, PharmD. Last updated on 26.06.2023

Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Top 20 medicines with the same components:
Beclomethasone (Candiderma) is used for the control of bronchial asthma in persons requiring continuous treatment. Such patients may include those with frequent asthmatic episodes that require medications to dilate the airways in the lung or those with asthmatic episodes at night.
Small quantity of cream should be applied gently on the affected area, 2-3 times daily or as recommended.
Hypersensitivity to any of the ingredients of this preparation contraindicates its use.
Clotrimazole (Candiderma) Cream may cause damage to latex contraceptives. Consequently patient should be advised to use alternative precautions for at least five days after using this product.
The most commonly noted side effects associated with inhaled Beclomethasone (Candiderma) are mild cough or wheezing due to chemical irritation; these effects may be minimized by using an inhaled bronchodilator (e.g., albuterol or Ventolin) prior to the Beclomethasone (Candiderma).
Oral candidiasis or thrush, a fungal infection of the mouth and throat, can occur in between 1 in 20 and 1 in 8 persons who use Beclomethasone (Candiderma). The risk of thrush is greater with higher doses, but the risk in children is lower than in adults. Hoarseness may occur in as few as 1 in 20 or as many as 1 in 2 persons and is due to chemical irritation. A spacer device that can be attached to the inhaler and washing out the mouth with water following each use of Beclomethasone (Candiderma) reduces the amount of Beclomethasone (Candiderma) in the mouth and throat and reduces the risk of thrush and hoarseness.
Higher doses of inhaled Beclomethasone (Candiderma) (more than 1000 mcg/day) may result in more absorption into the body. This may decrease bone formation and increase bone breakdown (resorption), resulting in weak bones and a risk of fractures. Even higher doses (more than 1500 mcg/day in adults and 400 mcg/day in children) may suppress the adrenal glands and impair their ability to make natural glucocorticoid. People with such suppression (which can be identified by testing) need increased amounts of glucocorticoid orally or by the intravenous route during periods of high physical stress since higher amounts of glucocorticoids are needed by the body to fight physical stress. Patients receiving Beclomethasone (Candiderma) may develop easy bruising if enough Beclomethasone (Candiderma) is absorbed into the body from the lungs.